| Revenue growth | 13.2% YoY growth to ₹311 Cr in Q2 FY27. |
|---|---|
| Margins | Gurgaon margins peaked at 23.8%; consolidated operational EBITDA at 23.3%. |
| Demand visibility | Strong across cardiac, oncology, and neurosciences; international business stable at 30%. |
| Management confidence | Highly optimistic, emphasizing first-mover advantage in Raipur and clinical excellence. |
Growth
Consolidated revenue up 13.2% YoY to ₹311 Cr; Gurgaon EBITDA hit 23.8% record.
Outlook
Targets 2,000 beds in 3-5 years; Tower 4 adding 250 beds by H2FY28.
Risks
Potential regulatory caps on oncology drug margins could impact EBITDA by 0.5-0.8%.
Last quarter's promises, checked
Delivered
- Gurgaon EBITDA guided 20–21% FY27 → 23.8% (= BEAT)
- Consolidated margin guided beyond 21% → 23.3% (= BEAT)
- International share guided ~30% → 30% (= BEAT, at floor)
Partly delivered
- 2,000 beds guided by 2029–30 → now 3–5 yrs (= PARTIAL)
- Tower IV guided 200+ beds, start pending clearances → underway, 250 beds by H2FY28 (= PARTIAL)
- ₹700 Cr QIP guided in 6–8 months → fundraise planned Jan–Feb 2027 (= PARTIAL, pending)
Earnings Call Transcript filed with NSE, NSE: ARTEMISMED. Summary written with AI assistance from the document.
Artemis Medicare Services Ltd: key numbers
- Share price
- ₹283.60
- Market cap
- ₹4,490 Cr
- Revenue (annual)
- ₹1,081 Cr
- Net profit (annual)
- ₹103.6 Cr
- P/E (TTM)
- 39.1×Sector 52.8×
- Promoter holding
- 58.39%+0.00% QoQ
- FII holding
- 12.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Artemis Medicare Services Ltd
All →Artemis Medicare Services Other Announcement
Artemis Medicare filed CARE Ratings' quarterly monitoring report on its Rs.330 crore preferential issue. It reports no deviation, with proceeds used as per the disclosed objects.
Artemis Medicare Services Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue INR 31,104 Lacs (+13.2% YoY); adj. EBITDA INR 7,150 Lacs (+22.7%, 23.3% margin); PAT INR 3,110 Lacs (+3.7%). Raipur ramp-up dilutes reported margins.
Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Artemis Medicare Services Q2 FY27 Results: Net Profit ₹31.1 Cr, Up 3.7% YoY
Artemis Medicare Services Ltd reported revenue from operations of ₹311 Cr (+13.2% YoY) and net profit of ₹31.1 Cr (+3.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹31.1 Cr · +3.7% YoY
Artemis Medicare Services Board Meeting Date
Artemis Medicare scheduled a board meeting for Oct 30, 2026 to approve Q1 un-audited results. Trading window remains closed until Nov 1, 2026.
Artemis Medicare Services Other Announcement
Artemis Medicare Services Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI regulatory requirements.